Literature DB >> 33385323

Preclinical techniques to investigate exercise training in vascular pathophysiology.

Gurneet S Sangha1, Craig J Goergen2,3, Steven J Prior4,5, Sushant M Ranadive4, Alisa M Clyne1.   

Abstract

Atherosclerosis is a dynamic process starting with endothelial dysfunction and inflammation and eventually leading to life-threatening arterial plaques. Exercise generally improves endothelial function in a dose-dependent manner by altering hemodynamics, specifically by increased arterial pressure, pulsatility, and shear stress. However, athletes who regularly participate in high-intensity training can develop arterial plaques, suggesting alternative mechanisms through which excessive exercise promotes vascular disease. Understanding the mechanisms that drive atherosclerosis in sedentary versus exercise states may lead to novel rehabilitative methods aimed at improving exercise compliance and physical activity. Preclinical tools, including in vitro cell assays, in vivo animal models, and in silico computational methods, broaden our capabilities to study the mechanisms through which exercise impacts atherogenesis, from molecular maladaptation to vascular remodeling. Here, we describe how preclinical research tools have and can be used to study exercise effects on atherosclerosis. We then propose how advanced bioengineering techniques can be used to address gaps in our current understanding of vascular pathophysiology, including integrating in vitro, in vivo, and in silico studies across multiple tissue systems and size scales. Improving our understanding of the antiatherogenic exercise effects will enable engaging, targeted, and individualized exercise recommendations to promote cardiovascular health rather than treating cardiovascular disease that results from a sedentary lifestyle.

Entities:  

Keywords:  atherosclerosis; bionengineering; cardiovascular; exercise; preclinical

Mesh:

Year:  2021        PMID: 33385323      PMCID: PMC8260379          DOI: 10.1152/ajpheart.00719.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  446 in total

Review 1.  Assessment and management of atherosclerosis in the athletic patient.

Authors:  Matthew W Parker; Paul D Thompson
Journal:  Prog Cardiovasc Dis       Date:  2012 Mar-Apr       Impact factor: 8.194

2.  Shear stress regulates occludin content and phosphorylation.

Authors:  L DeMaio; Y S Chang; T W Gardner; J M Tarbell; D A Antonetti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-07       Impact factor: 4.733

3.  Interstrain variation in murine aerobic capacity.

Authors:  J T Lightfoot; M J Turner; K A Debate; S R Kleeberger
Journal:  Med Sci Sports Exerc       Date:  2001-12       Impact factor: 5.411

4.  Ultrastructure of early lipid accumulation in ApoE-deficient mice.

Authors:  M Tamminen; G Mottino; J H Qiao; J L Breslow; J S Frank
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

5.  NEMA NU 4-2008 comparison of preclinical PET imaging systems.

Authors:  Andrew L Goertzen; Qinan Bao; Mélanie Bergeron; Eric Blankemeyer; Stephan Blinder; Mario Cañadas; Arion F Chatziioannou; Katherine Dinelle; Esmat Elhami; Hans-Sonke Jans; Eduardo Lage; Roger Lecomte; Vesna Sossi; Suleman Surti; Yuan-Chuan Tai; Juan José Vaquero; Esther Vicente; Darin A Williams; Richard Laforest
Journal:  J Nucl Med       Date:  2012-06-14       Impact factor: 10.057

Review 6.  Endothelial dysfunction and vascular disease - a 30th anniversary update.

Authors:  P M Vanhoutte; H Shimokawa; M Feletou; E H C Tang
Journal:  Acta Physiol (Oxf)       Date:  2016-01-25       Impact factor: 6.311

7.  Exercise-based cardiac rehabilitation for adults with heart failure.

Authors:  Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-01-29

8.  Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow.

Authors:  J R Allport; W A Muller; F W Luscinskas
Journal:  J Cell Biol       Date:  2000-01-10       Impact factor: 10.539

9.  Velocity mapping of the aortic flow at 9.4 T in healthy mice and mice with induced heart failure using time-resolved three-dimensional phase-contrast MRI (4D PC MRI).

Authors:  Philipp Rene Bovenkamp; Tobias Brix; Florian Lindemann; Richard Holtmeier; Desiree Abdurrachim; Michael T Kuhlmann; Gustav J Strijkers; Jörg Stypmann; Klaus H Hinrichs; Verena Hoerr
Journal:  MAGMA       Date:  2014-11-08       Impact factor: 2.310

10.  Resistance exercise reduced the expression of fibroblast growth factor-2 in skeletal muscle of aged mice.

Authors:  Jin-Soo Kim; Dong Hyun Yoon; Hee-Jae Kim; Mi-Jung Choi; Wook Song
Journal:  Integr Med Res       Date:  2016-05-07
View more
  4 in total

1.  Effects of swimming on the development of atherosclerosis in mice.

Authors:  Longpu Zhang; Jian Chi; Junxia Chen; Shiqin Jiang; Di Wu
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Estrogen Promotes Microvascularization in the Fetus and Thus Vascular Function and Insulin Sensitivity in Offspring.

Authors:  Eugene D Albrecht; Graham W Aberdeen; Jeffery S Babischkin; Steven J Prior; Terrie J Lynch; Irene A Baranyk; Gerald J Pepe
Journal:  Endocrinology       Date:  2022-05-01       Impact factor: 5.051

3.  Association between Urinary Phthalate Metabolites and Markers of Endothelial Dysfunction in Adolescents and Young Adults.

Authors:  Po-Ching Chu; Charlene Wu; Ta-Chen Su
Journal:  Toxics       Date:  2021-02-06

Review 4.  The Role of Exercise-Induced Molecular Processes and Vitamin D in Improving Cardiorespiratory Fitness and Cardiac Rehabilitation in Patients With Heart Failure.

Authors:  Aneta Aleksova; Milijana Janjusevic; Giulia Gagno; Alessandro Pierri; Laura Padoan; Alessandra Lucia Fluca; Cosimo Carriere; Antonio Paolo Beltrami; Gianfranco Sinagra
Journal:  Front Physiol       Date:  2022-01-11       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.